Juan F Delgado1,2, Andreu Ferrero Gregori3,4, Laura Morán Fernández5, Ramón Bascompte Claret6,7, Andrés Grau Sepúlveda8, Francisco Fernández-Avilés9,10, José R González-Juanatey11,12, Rafael Vázquez García13, Miguel Rivera Otero14, Javier Segovia Cubero15, Domingo Pascual Figal16,17, Maria G Crespo-Leiro18, Jesús Alvarez-García3, Juan Cinca3,4, Fernando Arribas Ynsaurriaga5,9. 1. Cardiology Department, University Hospital 12 de Octubre, Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), Av de Córdoba sn, 28041, Madrid, Spain. juan.delgado@salud.madrid.org. 2. CIBERCV; Facultad de Medicina, Universidad Complutense de Madrid, Madrid, Spain. juan.delgado@salud.madrid.org. 3. Cardiology Department, University Hospital Santa Creu i Sant Pau, Barcelona, Spain. 4. Facultad de Medicina, Universitat Autònoma de Barcelona, Barcelona, Spain. 5. Cardiology Department, University Hospital 12 de Octubre, Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), Av de Córdoba sn, 28041, Madrid, Spain. 6. Cardiology Department, Hospital Universitari Arnau de Vilanova, Lleida, Spain. 7. IRBLLEIDA, Lleida, Spain. 8. Cardiology Department, University Hospital Son Espases, Palma de Mallorca, Spain. 9. CIBERCV; Facultad de Medicina, Universidad Complutense de Madrid, Madrid, Spain. 10. Cardiology Department, University Hospital Gregorio Marañón, Madrid, Spain. 11. CIBERCV; Cardiology Department, University Hospital Santiago de Compostela, Santiago de Compostela, Spain. 12. Facultad de Medicina, Universidad de Santiago, Santiago de Compostela, Spain. 13. Cardiology Department, University Hospital Puerta del Mar, Cádiz, Spain. 14. CIBERCV; Cardiology Department, University Hospital La Fe, Valencia, Spain. 15. CIBERCV; Cardiology Department, University Hospital Puerta de Hierro-Majadahonda, Madrid, Spain. 16. CIBERCV; Cardiology Department, University Hospital Virgen de la Arrixaca, Murcia, Spain. 17. Facultad de Medicina, Universidad de Murcia, Murcia, Spain. 18. CIBERCV; University Hospital de A Coruña, Instituto de Investigación Biomédica de A Coruña (INIBIC), Universidad de A Coruña (UDC), A Coruña, Spain.
Abstract
BACKGROUND: Identifying readmission predictors in heart failure (HF) patients may help guide preventative efforts and save costs. We aimed to identify 15- and 30-day readmission predictors due to cardiovascular reasons. METHODS AND RESULTS: A total of 1831 patients with acute HF admission were prospectively followed during a year. Patient-associated variables were gathered at admission/discharge and events during follow-up. A multivariate Fine and Gray competing risk regression model and a cumulative incidence function were used to identify predictors and build a risk score model for 15- and 30-day readmission. The 15- and 30-day readmission rates due to cardiovascular reasons were 7.1% and 13.9%. Previous acute myocardial infarction, congestive signs at discharge, and length of stay > 9 days were predictors of 15- and 30-day readmission, while much weight loss and large NT-ProBNP reduction were protective factors. The NT-ProBNP reduction was larger at 30 days (> 55%) vs 15 days (> 40%) to protect from readmission. Glomerular filtration rate at discharge < 60 mL/min/1.73m2 and > 1 previous admissions due to HF were predictors of 30-day readmission, while first post-discharge control at an HF unit was a protective factor. CONCLUSIONS: Previous identified factors for early readmission were confirmed. The NT-ProBNP reduction should be increased (> 55%) to protect from 30-day readmission.
BACKGROUND: Identifying readmission predictors in heart failure (HF) patients may help guide preventative efforts and save costs. We aimed to identify 15- and 30-day readmission predictors due to cardiovascular reasons. METHODS AND RESULTS: A total of 1831 patients with acute HF admission were prospectively followed during a year. Patient-associated variables were gathered at admission/discharge and events during follow-up. A multivariate Fine and Gray competing risk regression model and a cumulative incidence function were used to identify predictors and build a risk score model for 15- and 30-day readmission. The 15- and 30-day readmission rates due to cardiovascular reasons were 7.1% and 13.9%. Previous acute myocardial infarction, congestive signs at discharge, and length of stay > 9 days were predictors of 15- and 30-day readmission, while much weight loss and large NT-ProBNP reduction were protective factors. The NT-ProBNP reduction was larger at 30 days (> 55%) vs 15 days (> 40%) to protect from readmission. Glomerular filtration rate at discharge < 60 mL/min/1.73m2 and > 1 previous admissions due to HF were predictors of 30-day readmission, while first post-discharge control at an HF unit was a protective factor. CONCLUSIONS: Previous identified factors for early readmission were confirmed. The NT-ProBNP reduction should be increased (> 55%) to protect from 30-day readmission.
Authors: Patricia S Keenan; Sharon-Lise T Normand; Zhenqiu Lin; Elizabeth E Drye; Kanchana R Bhat; Joseph S Ross; Jeremiah D Schuur; Brett D Stauffer; Susannah M Bernheim; Andrew J Epstein; Yongfei Wang; Jeph Herrin; Jersey Chen; Jessica J Federer; Jennifer A Mattera; Yun Wang; Harlan M Krumholz Journal: Circ Cardiovasc Qual Outcomes Date: 2008-09
Authors: Clyde W Yancy; Mariell Jessup; Biykem Bozkurt; Javed Butler; Donald E Casey; Monica M Colvin; Mark H Drazner; Gerasimos S Filippatos; Gregg C Fonarow; Michael M Givertz; Steven M Hollenberg; JoAnn Lindenfeld; Frederick A Masoudi; Patrick E McBride; Pamela N Peterson; Lynne Warner Stevenson; Cheryl Westlake Journal: J Am Coll Cardiol Date: 2017-04-28 Impact factor: 24.094
Authors: Inés Gómez-Otero; Andreu Ferrero-Gregori; Alfonso Varela Román; José Seijas Amigo; Domingo A Pascual-Figal; Juan Delgado Jiménez; Jesús Álvarez-García; Francisco Fernández-Avilés; Fernando Worner Diz; Luis Alonso-Pulpón; Juan Cinca; José Ramón Gónzalez-Juanatey Journal: Rev Esp Cardiol (Engl Ed) Date: 2016-12-21
Authors: Harlan M Krumholz; Sarwat I Chaudhry; John A Spertus; Jennifer A Mattera; Beth Hodshon; Jeph Herrin Journal: JACC Heart Fail Date: 2015-12-02 Impact factor: 12.035
Authors: Jesús Álvarez-García; Andreu Ferrero-Gregori; Teresa Puig; Rafael Vázquez; Juan Delgado; Domingo Pascual-Figal; Luis Alonso-Pulpón; José R González-Juanatey; Miguel Rivera; Fernando Worner; Alfredo Bardají; Juan Cinca Journal: Eur J Heart Fail Date: 2015-05-23 Impact factor: 15.534
Authors: Òscar Miró; Xavier Rossello; Elke Platz; Josep Masip; Danielle M Gualandro; W Frank Peacock; Susanna Price; Louise Cullen; Salvatore DiSomma; Mucio Tavares de Oliveira; John Jv McMurray; Francisco J Martín-Sánchez; Alan S Maisel; Christiaan Vrints; Martin R Cowie; Héctor Bueno; Alexandre Mebazaa; Christian Mueller Journal: Eur Heart J Acute Cardiovasc Care Date: 2020-08